Akademik Veri Yönetim Sistemi
PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY, cilt.27, sa.1, ss.19-23, 2017 (SCI-Expanded)
Objective: Clozapine and risperidone are used for treatment-resistant schizophrenia and known to improve the positive and negative symptoms. However, there are some conflicts about effects on social cognition, which is measured with facial emotion recognition ability. The impairments in facial emotion recognition ability have frequently been in different stages of the illness and might have negative influences on psychosocial functioning. In the present study, we aimed to examine clozapine and risperidone effects recognizing facial emotions in patient with treatment-resistant schizophrenia.